Selective killing of leukaemia cells by antibody–toxin conjugates: implications for autologous bone marrow transplantation
- 1 February 1982
- journal article
- Published by Springer Nature in Nature
- Vol. 295 (5850), 604-605
- https://doi.org/10.1038/295604a0
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Diversity of immunoglobulin expression in leukaemic cells resembling B-lymphocyte precursorsNature, 1981
- Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cellsNature, 1981
- Induction of murine B cell proliferation by insolubilized anti-immunoglobulins.The Journal of Immunology, 1980
- Selective killing of normal or neoplastic B cells by antibodies coupled to the A chain of ricin.Proceedings of the National Academy of Sciences, 1980
- Antibody-directed cytotoxic agents: use of monoclonal antibody to direct the action of toxin A chains to colorectal carcinoma cells.Proceedings of the National Academy of Sciences, 1980
- Autologous Bone Marrow Transplantation in Patients With CancerJAMA, 1980
- BCL1, a Murine Model for Chronic Lymphocytic Leukemia: Use of the Surface Immunoglobulin Idiotype for the Detection and Treatment of TumorImmunological Reviews, 1979
- Murine B Cell Leukemia (BCL1): Organ Distribution and Kinetics of Growth as Determined by Fluorescence Analysis with an Anti-Idiotypic AntibodyThe Journal of Immunology, 1979
- Spontaneous murine B-cell leukaemiaNature, 1978
- Prolymphocytic LeukaemiaBritish Journal of Haematology, 1974